Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
The price of AdaptHealth Corp (NASDAQ: AHCO) closed at $11.09 in the last session, down -0.09% from day before closing price of $11.10. In other words, the price has decreased by -$0.09 from its previous closing price. On the day, 2.69 million shares were traded.
Ratios:
We take a closer look at AHCO’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 13.63 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 6.34. For the most recent quarter (mrq), Quick Ratio is recorded 1.09 and its Current Ratio is at 1.33. In the meantime, Its Debt-to-Equity ratio is 1.36 whereas as Long-Term Debt/Eq ratio is at 1.32.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Jefferies on January 08, 2024, Downgraded its rating to Hold and sets its target price to $8 from $14.50 previously.
On November 08, 2023, BofA Securities Downgraded its rating to Underperform which previously was Neutral and also lowered its target price recommendation from $9.50 to $6.50.
Stifel Downgraded its Buy to Hold on May 10, 2023, whereas the target price for the stock was revised from $18 to $11.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Dec 19 ’24 when Rietkerk Shaw bought 32,500 shares for $9.70 per share.
Clemens Jason A sold 35,000 shares of AHCO for $327,250 on Dec 10 ’24. The Chief Financial Officer now owns 420,719 shares after completing the transaction at $9.35 per share. On Dec 10 ’24, another insider, JASON A CLEMENS &BIANCA S VITA, who serves as the Officer of the company, bought 35,000 shares for $9.35 each.
Valuation Measures:
As of this moment, AdaptHealth’s Price-to-Earnings (P/E) ratio for their current fiscal year is 18.34, and their Forward P/E ratio for the next fiscal year is 9.31. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.44. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.46 while its Price-to-Book (P/B) ratio in mrq is 0.95.
Stock Price History:
Over the past 52 weeks, AHCO has reached a high of $11.90, while it has fallen to a 52-week low of $8.35. The 50-Day Moving Average of the stock is 12.09%, while the 200-Day Moving Average is calculated to be 7.96%.
Shares Statistics:
A total of 134.60M shares are outstanding, with a floating share count of 86.49M. Insiders hold about 35.87% of the company’s shares, while institutions hold 73.63% stake in the company.
